Trials / Completed
CompletedNCT02225912
A Study to Evaluate the Efficacy of the Nasal Antiseptic, PrevinC, When Administered for the RiskReduction of Rhinitis in Subjects Who Work for Child Day Care Centers
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- BioHealth Technologies Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- —
Summary
The hypothesis was to establish whether the use of PrevinC administered nasally 2-3 times a day will prevent upper respiratory infections in otherwise healthy adults working in child day care centers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | PrevinC | |
| DRUG | placebo |
Timeline
- Start date
- 2005-02-01
- Primary completion
- 2005-05-01
- Completion
- 2005-05-01
- First posted
- 2014-08-26
- Last updated
- 2019-01-16
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02225912. Inclusion in this directory is not an endorsement.